CD8A and neoplasm: In addition to tumor cells, components that may be associated with primary or acquired drug resistance include tumor-infiltrating lymphocytes, CD8+ T-cell depletion, tumor-associated immunosuppressive cells, and other suppressive immune checkpoints.